Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: oral

Currently viewing:

Administrative data

acute toxicity: oral
Type of information:
migrated information: read-across from supporting substance (structural analogue or surrogate)
Adequacy of study:
key study
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Comparable to OECD 401 guideline study with acceptable restrictions [Body weight was only determined at the beginning of the study (OECD: weekly); Observation period: 7 days (OECD:14 days)]

Data source

Reference Type:
study report
Report date:

Materials and methods

Principles of method if other than guideline:
BASF-TEST: In principle, the methods described in the OECD Guideline 401 were used. Young adult laboratory rats were purchased from breeder. Usually the source and strain of animals were not documented. Several groups of 5 rats per sex and dose were treated simultaneously by gavage with preparations of the test substance in suitable vehicle. The concentrations of these preparations were used to achieve comparable volumes per kg body weight. Group-wise documentation of clinical signs was performed over the 7 day study period. Body weight was determined before the start of the study only, as it was needed for determination of dose
GLP compliance:
Test type:
standard acute method

Test material

Constituent 1
Chemical structure
Reference substance name:
Disodium dihydrogen ethylenediaminetetraacetate
EC Number:
EC Name:
Disodium dihydrogen ethylenediaminetetraacetate
Cas Number:
Molecular formula:
disodium dihydrogen 2,2',2'',2'''-(ethane-1,2-diyldinitrilo)tetraacetate
Details on test material:
no data

Test animals

not specified
Details on test animals or test system and environmental conditions:
- Mean body weight at study initiation:
259 g males/ 211 g females

Administration / exposure

Route of administration:
oral: gavage
CMC (carboxymethyl cellulose)
Details on oral exposure:
- Stock solutions prepared:
- Dose volume applied:
2500 mg/kg bw dose group: 8.33 ml/kg bw
3200 mg/kg bw dose group: 10.66 ml/kg bw
4000 mg/kg bw dose group: 13.33 ml/kg bw
5000 mg/kg bw dose group: 16.66 ml/kg bw
6400 mg/kg bw dose group: 21.4 ml/kg bw
2500; 3200; 4000; 5000; 6400 mg/kg bw
No. of animals per sex per dose:
Control animals:
Details on study design:
- Duration of observation period following administration: 7 days;
- The animals were observed for mortality and clinical signs of toxicity;
- Frequency of observations: Several times on the application day, thereafter once each working day;
- Body weights were only recorded at the beginning of the study;
- Necropsy of survivors and animals which died performed: yes

Results and discussion

Effect levels
Dose descriptor:
Effect level:
2 800 mg/kg bw
- One female died in the 2500 mg/kg bw dose group; 9/10 animals died in the 3200 mg/kg bw dose group and all animals of the higher dose groups (see table 1).
Clinical signs:
other: - 2500, 3200 and 4000 mg/kg bw: directly after application: accelerated respiration, squatting posture, twitching, ataxia, red eyes, some animals showed light secretion, reluctance to move; the next day: squatting posture, contaminated fur, intermittened
Gross pathology:
Animals which died:
- heart: acute dilatation, venous hyperemia
- liver: congestion
- gut: diarrhea like content
- stomach: dilatation
- kidneys: degeneration
Animals which were sacrificed:
- nothing abnormal detected

Any other information on results incl. tables

Table 1: Mortalities of rats after oral application

2500 mg/kg bw 3200 mg/kg bw 4000 mg/kg bw 5000 mg/kg bw 6400 mg/kg bw
1 h male  0/5 0/5 0/5 0/5 0/5
female 0/5 0/5 0/5 0/5 0/5
24 h male  0/5 3/5 5/5 5/5 5/5
female 1/5 5/5 5/5 5/5 5/5
48 h male  0/5 3/5 5/5 5/5 5/5
female 1/5 5/5 5/5 5/5 5/5
7 d male  0/5 4/5 5/5 5/5 5/5
female 1/5 5/5 5/5 5/5 5/5

Applicant's summary and conclusion